Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

Google will spend $85 billion on artificial-intelligence projects this year. Its rivals are likely to spend more.

The EC has approved Janssen-Cilag International’s new indication for Darzalex Faspro (daratumumab) to treat adults with SMM.

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...

Paul Walsh, founder and managing partner of Walsh Barnes, is winding down his practice after 35 years to launch his own ...

As earnings season gains momentum, next week’s slate features heavyweights across tech, energy, industrials, and consumer sectors, offering a broad pulse on corporate health and macro conditions.

Overview of Breast Cancer Therapeutics MarketThe Global Breast Cancer Therapeutics Market is valued at USD 33.83 Billion in ...